Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cambrex Corp (CBM)

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,023,102
  • Shares Outstanding, K 33,724
  • Annual Sales, $ 532,090 K
  • Annual Income, $ 92,420 K
  • 60-Month Beta 2.13
  • Price/Sales 3.80
  • Price/Cash Flow 15.36
  • Price/Book 2.99
Trade CBM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.60
  • Most Recent Earnings 0.31 on 05/02/19
  • Next Earnings Date 11/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 14.000 on 05/04/07
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +2,497,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.72 +0.45%
on 11/04/19
59.99 unch
on 12/03/19
+0.19 (+0.32%)
since 11/01/19
3-Month
59.38 +1.03%
on 10/02/19
60.14 -0.25%
on 09/06/19
+0.43 (+0.72%)
since 09/03/19
52-Week
33.80 +77.49%
on 02/14/19
60.29 -0.50%
on 08/14/19
+10.73 (+21.78%)
since 12/03/18

Most Recent Stories

More News
BioFlyte Forms Scientific Advisory Board of Prominent Government and Life Science Experts

BioFlyte , a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced the formation of a Scientific Advisory...

NVIV : 2.20 (+2.41%)
PKI : 139.23 (-1.78%)
CBM : 59.99 (unch)
Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility

EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...

CBM : 59.99 (unch)
Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit

EAST RUTHERFORD, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...

CBM : 59.99 (unch)
Cambrex Announces Management Changes and Board Appointments

EAST RUTHERFORD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug...

CBM : 59.99 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 60.00
1st Resistance Point 59.99
Last Price 59.99
1st Support Level 59.98
2nd Support Level 59.98
3rd Support Level N/A

See More

52-Week High 60.29
Last Price 59.99
Fibonacci 61.8% 50.17
Fibonacci 50% 47.04
Fibonacci 38.2% 43.92
52-Week Low 33.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar